Join an Observational Pregnancy Study on Lupus
Help future moms and babies by enrolling into our Benlysta & Pregnancy study.
MotherToBaby is currently enrolling pregnant people in a study examining the use of Benlysta (belimumab) when taken during pregnancy. If you’ve taken Benlysta and are pregnant, you may qualify for this important study. Our study includes:
- 1-3 phone interviews during your pregnancy and at least 1 interview after you have your baby.
- Your permission to obtain a copy of your and your baby’s medical records from your healthcare providers.
- An opportunity to receive a specialized, non-invasive exam of your baby with a study doctor
“Help us improve the ability for pregnant people and their healthcare providers to make safe treatment decisions by joining our Benlysta & Pregnancy study.”
— Christina Chambers, PhD, MPH, MotherToBaby Pregnancy Studies
If you have lupus and are pregnant, you may qualify to join this important study.
Join our Benlysta Study
Your information is confidential.
Questions? Call 866.626.6847 | Text 855.999.3525 | Email or Chat at MotherToBaby.org.
Disclaimer: MotherToBaby Fact Sheets are meant for general information purposes and should not replace the advice of your health care provider. MotherToBaby is a service of the non-profit Organization of Teratology Information Specialists (OTIS). OTIS/MotherToBaby encourages inclusive and person-centered language. While our name still contains a reference to mothers, we are updating our resources with more inclusive terms. Use of the term mother or maternal refers to a person who is pregnant. Use of the term father or paternal refers to a person who contributes sperm. Copyright by OTIS, June 23, 2021.